Blackstone Group »

Dyne Therapeutics shares owned by Blackstone Group

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Blackstone Group from 13F filings

Historical chart of Blackstone Group investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Blackstone Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.0M 57k 18.13

More positions owned by Blackstone Group

Cheniere Energy Partners Com Unit (CQP)
Corebridge Finl (CRBG)
FirstEnergy (FE)
Legence Corp Cl A (LGN)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Williams Companies (WMB)
MPLX Com Unit Rep Ltd (MPLX)
Targa Res Corp (TRGP)
Enterprise Products Partners (EPD)
Enbridge (ENB)
Kinder Morgan (KMI)
Energy Transfer Com Ut Ltd Ptn (ET)
Kinetik Holdings Com New Cl A (KNTK)
Cheniere Energy Com New (LNG)
PNM Resources (TXNM)

View all positions for Blackstone Group

Top funds holding Dyne Therapeutics

T. Rowe Price Investment Management
Henderson Group
BlackRock
Vanguard Group
Atlas Venture Life Science Advisors
Orbis Allan Gray
State Street Corporation
FMR
Vanguard Capital Management
Fcpm Iii Services B.v.
Adage Capital Partners GP
Perceptive Advisors
TCG Crossover Management
Vanguard Portfolio Management
Vestal Point Capital

View all funds holding Dyne Therapeutics